Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

101112131415161718

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

1st Nov 2023 08:50

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings. Read More

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

1st Nov 2023 07:40

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision. Read More

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

30th Oct 2023 09:01

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial. Read More

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

26th Oct 2023 09:19

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria. Read More

UK earnings, trading statements calendar - next 7 days

25th Oct 2023 16:01

Read More

GSK says RSV jab shows promising response in adults aged 50 to 59

25th Oct 2023 09:35

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59. Read More

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

16th Oct 2023 08:09

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer. Read More

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

16th Oct 2023 07:44

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere. Read More

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

11th Oct 2023 09:17

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning: Read More

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

11th Oct 2023 08:51

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank. Read More

TOP NEWS: GSK reaches settlement for Zantac litigation in California

11th Oct 2023 08:36

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer. Read More

LONDON BRIEFING: Stocks lower; GSK settles Zantac case in California

11th Oct 2023 07:47

(Alliance News) - Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day. Read More

TOP NEWS: GSK inks agreement with Zhifei to promote shingles vaccine

9th Oct 2023 08:16

(Alliance News) - GSK PLC on Monday said it has reached an exclusive agreement with Chongqing Zhifei Biological Products Ltd to co-promote its shingles vaccine, Shingrix, in China. Read More

LONDON BRIEFING: Metro Bank secures deal to shore up finances

9th Oct 2023 07:42

(Alliance News) - Stocks in London are set to open higher on Monday as interest rate expectations held steady despite Friday's bumper US nonfarm payrolls report. Read More

UPDATE: GSK banks GBP886 million from Haleon share sale

6th Oct 2023 07:57

(Alliance News) - GSK PLC on Friday said it received GBP885.6 million in gross proceeds from its sale of shares in consumer healthcare spin-off Haleon PLC. Read More

LONDON BRIEFING: Wetherspoon swings to profit; UK house prices fall

6th Oct 2023 07:46

(Alliance News) - Stocks in London are called to open higher on Friday, as investors eye a key nonfarm payroll reading in the US. Read More

UK dividends calendar - next 7 days

5th Oct 2023 15:47

Read More

IN BRIEF: GSK's Jemperli approved in UK for endometrial cancer

3rd Oct 2023 18:19

GSK PLC - London-based pharmaceutical company - On Monday, announces that the UK Medicines & Health Products Regulatory Agency has authorised a new indication for Jemperli, also known as dostarlimab. The drug is used as a treatment for some types of endometrial cancer and an be used to treat patients that have a tumour abnormality called mismatch repair deficient/microsatellite instability-high when the cancer is at an advanced stage when first diagnosed or has returned after previous treatment. It is now authorised to be used together with chemotherapy to slow the progression of these cancers. GSK says it is the first medicine licensed as first line treatment for primary advanced or recurrent endometrial cancer. Read More

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

3rd Oct 2023 11:59

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers. Read More

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

25th Sep 2023 09:13

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning: Read More

101112131415161718
FTSE 100 Latest
Value8,809.74
Change53.53